de Hon O - Search Results

1

β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.

Pluim BM, de Hon O, Staal JB, Limpens J, Kuipers H, Overbeek SE, Zwinderman AH, Scholten RJ. Pluim BM, et al. Among authors: de hon o. Sports Med. 2011 Jan 1;41(1):39-57. doi: 10.2165/11537540-000000000-00000. Sports Med. 2011. PMID: 21142283 Review.

2

Four weeks' corticosteroid inhalation does not augment maximal power output in endurance athletes.

Kuipers H, Van't Hullenaar GA, Pluim BM, Overbeek SE, De Hon O, Van Breda EJ, Van Loon LC. Kuipers H, et al. Among authors: de hon o. Br J Sports Med. 2008 Nov;42(11):868-71. doi: 10.1136/bjsm.2007.042572. Epub 2008 Mar 14. Br J Sports Med. 2008. PMID: 18344386 Clinical Trial.

3

Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes.

van Baak MA, de Hon OM, Hartgens F, Kuipers H. van Baak MA, et al. Among authors: de hon om. Int J Sports Med. 2004 Oct;25(7):533-8. doi: 10.1055/s-2004-815716. Int J Sports Med. 2004. PMID: 15459835 Clinical Trial.

4

Prevalence of doping use in elite sports: a review of numbers and methods.

de Hon O, Kuipers H, van Bottenburg M. de Hon O, et al. Sports Med. 2015 Jan;45(1):57-69. doi: 10.1007/s40279-014-0247-x. Sports Med. 2015. PMID: 25169441 Review.

5

Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.

Gleaves J, Petróczi A, Folkerts D, de Hon O, Macedo E, Saugy M, Cruyff M. Gleaves J, et al. Among authors: de hon o. Sports Med. 2021 Sep;51(9):1909-1934. doi: 10.1007/s40279-021-01477-y. Epub 2021 Apr 26. Sports Med. 2021. PMID: 33900578

6

Gene doping.

Haisma HJ, de Hon O. Haisma HJ, et al. Among authors: de hon o. Int J Sports Med. 2006 Apr;27(4):257-66. doi: 10.1055/s-2006-923986. Int J Sports Med. 2006. PMID: 16572366 Review.

7

Gene doping: an overview and current implications for athletes.

van der Gronde T, de Hon O, Haisma HJ, Pieters T. van der Gronde T, et al. Among authors: de hon o. Br J Sports Med. 2013 Jul;47(11):670-8. doi: 10.1136/bjsports-2012-091288. Epub 2013 Jan 15. Br J Sports Med. 2013. PMID: 23322893 Review.

8

Undeclared Doping Substances are Highly Prevalent in Commercial Sports Nutrition Supplements.

Duiven E, van Loon LJC, Spruijt L, Koert W, de Hon OM. Duiven E, et al. Among authors: de hon om. J Sports Sci Med. 2021 Mar 22;20(2):328-338. doi: 10.52082/jssm.2021.328. eCollection 2021 Jun. J Sports Sci Med. 2021. PMID: 34211326 Free PMC article.

9

Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial.

Heuberger JAAC, Rotmans JI, Gal P, Stuurman FE, van 't Westende J, Post TE, Daniels JMA, Moerland M, van Veldhoven PLJ, de Kam ML, Ram H, de Hon O, Posthuma JJ, Burggraaf J, Cohen AF. Heuberger JAAC, et al. Among authors: de hon o, de kam ml. Lancet Haematol. 2017 Aug;4(8):e374-e386. doi: 10.1016/S2352-3026(17)30105-9. Epub 2017 Jun 29. Lancet Haematol. 2017. PMID: 28669689 Clinical Trial.

10

The continuing story of nutritional supplements and doping infractions.

de Hon O, Coumans B. de Hon O, et al. Br J Sports Med. 2007 Nov;41(11):800-5; discussion 805. doi: 10.1136/bjsm.2007.037226. Br J Sports Med. 2007. PMID: 17957017 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters